Profilo
Garth Lees-Rolfe currently works at Ludwig Enterprises, Inc., as Independent Director from 2025.
Mr. Lees-Rolfe also formerly worked at F-star Therapeutics, Inc., as Vice President-Finance from 2021 to 2022 and Inhibikase Therapeutics, Inc., as Chief Financial & Accounting Officer from 2024 to 2025.
Mr. Lees-Rolfe received his undergraduate degree from Queensland University of Technology.
Posizioni attive di Garth Lees-Rolfe
| Società | Posizione | Inizio |
|---|---|---|
| LUDWIG ENTERPRISES, INC. | Direttore/Membro del Consiglio | 23/06/2025 |
Precedenti posizioni note di Garth Lees-Rolfe
| Società | Posizione | Fine |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Direttore Finanziario/CFO | 11/04/2025 |
| F-STAR THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2022 |
Formazione di Garth Lees-Rolfe
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Queensland University of Technology
Queensland University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig Enterprises, Inc.
Ludwig Enterprises, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
F-star Therapeutics, Inc.
F-star Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops antibody therapeutics for cancer and other diseases | Health Technology |
















